Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit (Details 1)

v3.23.2
Stockholders' Deficit (Details 1) - $ / shares
 6 Months Ended
Jun. 30, 2023
Jun. 14, 2023
Jan. 27, 2023
Dec. 31, 2022
Jul. 05, 2022
Class of Warrant or Right [Line Items]          
Beginning balance, outstanding 51,465,978     51,465,978  
Exercise price   $ 0.37 $ 0.88   $ 4.6
Issued        
Warrants exercised in Period, Weighted Average Grant Date Fair Value        
Warrants forfeited in Period, Weighted Average Grant Date Fair Value        
Two Thousand Nineteen Public Warrants [Member]          
Class of Warrant or Right [Line Items]          
Beginning balance, outstanding [1] 5,813,804     5,813,804  
Exercise price [1] $ 230        
Expiration Date [1] Jun. 19, 2024        
Issued [1]        
Warrants exercised in Period, Weighted Average Grant Date Fair Value [1]        
Warrants forfeited in Period, Weighted Average Grant Date Fair Value [1]        
Common Warrant [Member]          
Class of Warrant or Right [Line Items]          
Beginning balance, outstanding 43,478,261     43,478,261 [2]  
Exercise price $ 0.37 [2] 0.37 0.88    
Expiration Date [2] Jun. 29, 2027        
Issued [2]        
Warrants exercised in Period, Weighted Average Grant Date Fair Value [2]        
Warrants forfeited in Period, Weighted Average Grant Date Fair Value [2]        
Underwriter Warrants [Member]          
Class of Warrant or Right [Line Items]          
Beginning balance, outstanding [2] 2,173,913     2,173,913  
Exercise price $ 0.37 [2] $ 0.37 $ 0.88   $ 4.6
Expiration Date [2] Jun. 29, 2027        
Issued [2]        
Warrants exercised in Period, Weighted Average Grant Date Fair Value [2]        
Warrants forfeited in Period, Weighted Average Grant Date Fair Value [2]        
[1] The 2019 Public Warrants are exercisable for 290,690 shares of Common Stock at $230.00 per share or a ratio of 20 warrants for one share of Common Stock.
[2] In connection with the PIPE Investment, the exercise price of the Common Warrants and Underwriter Warrants was reduced from $0.88 per shares to $0.37 per share and are exercisable for a combined amount of 2,282,609 shares of Common Stock at $4.60 per share or a ratio of 20 warrants for one share of Common Stock.